Randomized trial examines board independence and CEO duality effects on firm performance in NASDAQ-100, suggesting implications for governance policies.
This study examines the effects of board independence and CEO duality on firm performance. We analyze data for the NASDAQ-100 firms over the period 2010-2014. Three measurements of board independence are used: (1) proportion of independent directors, (2) committee overlap, and (3) board interlock. We use an alternative and more appropriate definition of committee overlap and board interlock that only considers independent-director committee overlaps and interlocks. Our method includes the use of a treatment effect approach to control for endogenous issues that have likely caused mixed results in prior research. Several significant results are found from this study. First, independent-director committee overlaps are shown to have a significantly positive relationship with firm performance. Secondly, board interlocks of independent directors are also found to be positively associated with firm performance. Lastly, we find a negative relationship between CEO duality and firm performance. The relevance of these results is discussed from corporate governance policy and academic research perspectives.
No takes yet. Share an insight, caveat, or question.
Rutledge et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: